An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT05649722 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Hypertension
Interstitial Lung Disease

Interventions

DRUG: Treprostinil Palmitil Inhalation Powder
DRUG: Placebo

Sponsor

Insmed Incorporated